In this issue:
Serum vs. urine FLCs for evaluating light-chain MM response
Bendamustine, low-dose dexamethasone, lenalidomide for relapsed/refractory MM
Statins reduce mortality in MM
Progression of solitary plasmacytoma to MM
Upfront autologous SCT for newly diagnosed elderly MM
Adding cyclophosphamide and prednisone in lenalidomiderefractory MM
Ixazomib and dexamethasone in relapsed MM
Prognostic significance of cereblon expression in MM
Autologous transplant ±induction in elderly MM
Please login below to download this issue (PDF)